Visualizing biomolecular structures through cryo-EM studies can provide insight into multiple stages of the drug development process, from target identification through formulation and manufacturing. As the industry leader with the longest history in cryo-EM, and with more cryo-EM scientists and TEM microscopes than any provider in North America, NIS is focused on three areas of cutting-edge science: - Target Enablement, using high resolution single particle analysis for structure-based drug design. -Characterization, which includes complete morphology assessment to inform size, shape, uniformity, aggregation, purify, and cargo description, with quantitative analysis. -Small molecule MicroED, which provides high resolution structures of challenging samples. Diverse skill sets and state-of-the art technology help us make cryo-EM accessible to companies of all sizes, and to teams across the drug discovery pipeline. Through collaboration, learning, and a commitment to quality results, we help our clients accelerate the development of new and life changing therapeutics.